BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 23821770)

  • 1. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
    Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
    Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
    Iyer S; Scotney PD; Nash AD; Ravi Acharya K
    J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of growth factor binding and specificity by VEGF receptor 2.
    Leppänen VM; Prota AE; Jeltsch M; Anisimov A; Kalkkinen N; Strandin T; Lankinen H; Goldman A; Ballmer-Hofer K; Alitalo K
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2425-30. PubMed ID: 20145116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early signaling by vascular endothelial growth factor and placental growth factor in human bone marrow-derived endothelial cells is mediated by superoxide.
    Dhar-Mascareno M; Mascareno E; Golde DW
    J Vasc Res; 2009; 46(6):601-8. PubMed ID: 19571580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
    Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
    Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
    Mac Gabhann F; Popel AS
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung.
    Sands M; Howell K; Costello CM; McLoughlin P
    Respir Res; 2011 Jan; 12(1):17. PubMed ID: 21266048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
    Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
    Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model.
    Du H; Li P; Pan Y; Li W; Hou J; Chen H; Wang J; Tang H
    Brain Res; 2010 Oct; 1357():1-8. PubMed ID: 20637183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
    Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ
    Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
    J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
    Horta BA; Sodero AC; de Alencastro RB
    J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A.
    Markovic-Mueller S; Stuttfeld E; Asthana M; Weinert T; Bliven S; Goldie KN; Kisko K; Capitani G; Ballmer-Hofer K
    Structure; 2017 Feb; 25(2):341-352. PubMed ID: 28111021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
    Teran M; Nugent MA
    J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine papular stomatitis virus encodes a functionally distinct VEGF that binds both VEGFR-1 and VEGFR-2.
    Inder MK; Ueda N; Mercer AA; Fleming SB; Wise LM
    J Gen Virol; 2007 Mar; 88(Pt 3):781-791. PubMed ID: 17325350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
    Grummer MA; Sullivan JA; Magness RR; Bird IM
    Biochem J; 2009 Jan; 417(2):501-11. PubMed ID: 18816248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes.
    Freitas-Andrade M; Carmeliet P; Stanimirovic DB; Moreno M
    J Neurochem; 2008 Nov; 107(3):756-67. PubMed ID: 18786179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
    Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.